COVID-19 in Russia: Evolution of Views on the Pandemic. Report II

Author:

Starodubov Vladimir I.ORCID,Beregovykh Valery V.ORCID,Akimkin Vasily G.ORCID,Semenenko Tatiana A.ORCID,Ugleva Svetlana V.ORCID,Avdeev Sergey N.ORCID,Zykov Kirill A.ORCID,Trofimova Tatiana N.ORCID,Pogosova Nana V.ORCID,Perekhodov Sergey N.ORCID,Kuzin Stanislav N.ORCID,Yacyshina Svetlana B.ORCID,Petrov Vadim V.ORCID,Khafizov Kamil F.ORCID,Dubodelov Dmitry V.ORCID,Gasanov Gasan A.ORCID,Svanadze Nino Kh.ORCID,Cherkashina Anna S.ORCID,Sinitsyn Evgeny A.ORCID,Rvacheva Anna V.ORCID,Sergeeva Natal'ya V.,Polosova Tatiana A.,Zykova Alexandra A.ORCID,Zelenin Dmitrii A.ORCID,Gorbenko Mihail Yu.ORCID,Rodyukova Irina S.ORCID,Chaus Nikolay I.ORCID,Snitsar Artem V.ORCID

Abstract

Over the two years of the novel coronavirus infection (COVID-19) pandemic, there has been an evolution of views in various fields of medicine, which has led to a powerful development of scientific research in the field of epidemiology, clinic, diagnosis and therapy of COVID-19. This article discusses the evolution of views and approaches to the study of the clinic and therapy of COVID-19. The symptoms and aggravation of the course of cardiovascular diseases with COVID-19 have been established. The main strategy for organizing surgical care for patients with COVID-19 is indicated. The main criteria for the treatment of COVID-19, the need to prescribe SGCS on an individual basis, and the need to search for new methods of anti-inflammatory therapy for COVID-19, one of which may be the use of alkylating drugs in ultra-low doses, are described.

Publisher

Paediatrician Publishers LLC

Subject

General Medicine

Reference79 articles.

1. Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Wuhan, China: Wuhan Municipal Health Commission. Available from: http://wjw.wuhan.gov.cn/ front/web/showDetail/2019123108989 (In Chin.)

2. COVID-19 Research and Innovation. Powering the world’s pandemic response – now and in the future. Available from: https://cdn.who.int/media/docs/default-source/blue-print/achievement-report-_grif_web_finalversion15.pdf?sfvrsn=39052c73_9&download=true

3. COVID-19, MERS & SARS/NIH: National Institute of Allergy and Infectious Diseases. (n.d.). Retrieved September 6, 2020. Available from: https://www.niaid.nih.gov/diseases-conditions/covid-19

4. Коронавирус. Available from: https://coronavirus-monitor.info/

5. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3